References
-
1
Archer J S, Chang R J.
Hirsutism and acne in polycystic ovary syndrome.
Best Pract Res Clin Obstet Gynecol.
2004;
18
737-754
-
2
Azziz R.
The evaluation and management of hirsutism.
Obstet Gynecol.
2003;
101
995-1007
-
3
Azziz R, Sanchez L A, Knochenhauer E S, Moran C, Lazenby J, Stephens K C. et al .
Androgen excess in women: experience with over 1000 consecutive patients.
J Clin Endocrinol Metab.
2004;
89
453-462
-
4
Borgia F, Cannavo S, Guarneri F, Vannavo S P, Vaccaro M, Guarneri B.
Correlation between endocrinological parameters and acne severity in adult women.
Acta Dermatol Venerol.
2004;
84
201-204
-
5
Elmlinger M W, Kuhnel W, Wormstall H, Doller P C.
Reference intervals for testosterone, androstenedione and SHBG levels in healthy females and males from birth until old age.
Clin Lab.
2005;
51
625-632
-
6
Emadi-Konjin P, Bain J, Bromberg I L.
Evaluation of an algorithm for calculation of serum “bioavailable” testosterone (BAT).
Clin Biochem.
2003;
36
591-596
-
7
ESHRE Capri Workshop Group .
Anovulatory infertility.
Hum Reprod.
1995;
10
1549-1553
-
8
Falsetti L, Gambera A, Andrico S, Sartori E.
Acne and hirsutism in polycystic ovary syndrome: clinical, endocrine-metabolic and ultrasonographic differences.
Gynecol Endocrinol.
2002;
16
275-284
-
9
Ferriman D, Gallwey J D.
Clinical assessment of body hair growth in women.
J Clin Endocrinol Metab.
1961;
21
1440-1447
-
10
Hammond G L, Nisker J A, Jones L A, Siiteri P K.
Estimation of the percentage of free steroid in undiluted serum by centrifugal ultrafiltration-dialysis.
J Biol Chem.
1980;
255
5023-5026
-
11
Hart R, Hickey M, Franks S.
Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome.
Best Pract Res Clin Obstet Gynecol.
2004;
18
671-683
-
12
Hatch R, Rosenfield Rl, Moon H K, Tredway D.
Hirsutism: implications, etiology and management.
Am J Obstet Gynecol.
1981;
140
815-830
-
13
Laven J S, Imani B, Eijkemans J C, de Jong F H, Fauser B C.
Absent biologically relevant associations between serum inhibin B concentrations and characteristics of polycystic ovary syndrome in normogonadotrophic anovulatory infertility.
Hum Reprod.
2001;
16
1359-1364
-
14
Laven J S, Imani B, Eijkemans M J, Fauser B C.
New approach to polycystic ovary syndrome and other forms of anovulatory infertility.
Obstet Gynecol Surv.
2002;
57
755-767
-
15
Ly P L, Handelsman D J.
Empirical estimation of free testosterone from testosterone and sex hormone-binding globulin immunoassays.
Eur J Endocrinol.
2005;
152
471-478
-
16
Mathur R S, Moody L O, Landgrebbe S, Williamson H O.
Plasma androgens and sex hormone binding globulin in the evaluation of hirsute patients.
Fertil Steril.
1981;
35
29-37
-
17
McCann D S, Kirkish L S.
Evaluation of free testosterone in serum.
J Clin Immunoassay.
1985;
8
234-236
-
18
Ooi D S, Innanen V T, Wang D, Chong Gl, Donnelly J G, Arseneult J J. et al .
Establishing reference intervals for DPC's free testosterone radioimmunoassay.
Clin Biochem.
1998;
31
15-21
-
19
Rosner W.
Errors in the measurement of plasma free testosterone.
J Clin Endocrinol Metab.
1997;
82
2014-2015
-
20
Rotterdam ESHRE/ASRM-sponsored PCOS Consensus Workshop Group .
Revised 2003 consensus on diagnostic criteria and long term health risk related to polycystic ovary syndrome (PCOS).
Hum Reprod.
2004;
19
1-7
-
21
Rotterdam ESHRE/ASRM-sponsored PCOS Consensus Workshop Group .
Revised 2003 consensus on diagnostic criteria and long term health risk related to polycystic ovary syndrome (PCOS).
Fertil Steril.
2004;
81
19-25
-
22
Sodergard R, Backstrom T, Shanbhag V, Carstensen H.
Calculation of free and bound fractions of testosterone and estradiol-17 beta to human plasma proteins at body temperature.
J Steroid Biochem.
1982;
16
801-810
-
23
Souter I, Sanchez L A, Perez M, Bartolucci A A, Azziz R.
The prevalence of androgen excess among patients with minimal unwanted hair growth.
Am J Obstet Gynecol.
2004;
191
759-767
-
24
Thiboutot D, Chen W C.
Update and future of hormonal therapy in acne.
Dermatology.
2003;
206
57-67
-
25
Tsujimura A, Matsumiya K, Miyagawa Y, Takao T, Fujita K, Takada S. et al .
Comparative study on evaluation methods for serum testosterone level for PADAM diagnosis.
Int J Impot Res.
2005;
23
1-5
-
26
van Santbrink E J, Hop W C, Fauser B C.
Classification of normogonadotropic infertility: polycystic ovaries diagnosed by ultrasound versus endocrine characteristics of polycystic ovary syndrome.
Fertil Steril.
1997;
67
452-458
-
27
Van Uytfanghe K, Stöckle D, Kaufman J M, Fiers T, De Leenheer A, Thienpont L M.
Validation of 5 routine assays for serum free testosterone with a candidate reference measurement procedure based on ultrafiltration and isotope dilution-gas chromatography-mass spectrometry.
Clin Biochem.
2005;
38
253-261
-
28
Vermeulen A, Stoica T, Verdonck L.
The apparent free testosterone concentration, an index of androgenicity.
J Clin Endocrinol.
1971;
33
757-767
-
29
Vermeulen A, Verdonck L, Kaufmann J M.
A Critical evaluation of simple methods for the estimation of free testosterone in serum.
J Clin Endocrinol Metab.
1999;
84
3666-3672
-
30
Vlahos I, Macmahon W, Sgoutas D, Bowers W, Thompson J, Trawick W.
An improved ultrafiltration method for determining free testosterone in serum.
Clin Chem.
1982;
28
2286-2291
-
31
Wilke T J, Utley D J.
Total testosterone, free androgen index, calculated free testosterone and free testosterone by analog RIA compared in hirsute women and in otherwise normal women with altered binding of sex hormone binding globulin.
Clin Chem.
1987;
33
1372-1375
-
32 World Health Organization .WHO Manual for Standardized Investigation and Diagnosis of the Infertile Couple. Cambridge; Cambridge University Press 1993
-
33
Yucel A, Noyan V, Sagsoz N.
The association of serum androgens and insulin resistance with fat distribution in polycystic ovary syndrome.
Eur J Obstet Gynecol Reprod Biol.
2005;
6
DOI: 10.1016/j.ejogrb.2005.11.012
1 Andreas Mueller and Ralf Dittrich contributed equally to the authorship
Dr. Andreas Mueller
Department of Obstetrics and Gynecology
Erlangen University Hospital
Universitätsstraße 21 - 23
91054 Erlangen
Germany
Phone: + 49-9131-8533553
Fax: + 49-9131-8533552
Email: andreas.mueller@gyn.imed.uni-erlangen.de
